| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:26585008:978 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:26585008:978?format=raw |
LEADER: 00978cam a22002771 4500
001 4025637
005 20221027021248.0
008 820514s1953 xx b 000 0 eng d
035 $a(OCoLC)ocm14673383
035 $9AJY3840HS
035 $a(NNC)4025637
035 $a4025637
040 $aNLM$cNLM$dZCH
060 00 $aZQV 350$bB972a 1953
110 2 $aBurroughs Wellcome and Company.$0http://id.loc.gov/authorities/names/n80146293
245 10 $a'Aerosporin' (polymyxin B) sulfate, bibliography /$cfrom the Medical Department, and the Wellcome Research Laboratories.
250 $a2d ed.
260 $aNew York,$c1953.
300 $a25 leaves
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aCover title.
650 2 $aAnti-Bacterial Agents.$0https://id.nlm.nih.gov/mesh/D000900
655 7 $aBibliography.$2mesh$0https://id.nlm.nih.gov/mesh/D016417
710 2 $aWellcome Research Laboratories, London.
852 00 $boff,hsl$hRM666.A8$iB94 1953